Immuron Ltd ADR (IMRN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.84
• Market Cap: $7.45M
• EPS: $-0.64
• 52-Week High: $2.39
• 52-Week Low: $0.68

Market Sentiment

Immuron Ltd ADR currently has a Bullish sentiment score of 0.33.

About Immuron Ltd ADR

Immuron Ltd ADR is a biopharmaceutical company dedicated to developing innovative oral immunotherapy solutions harnessing polyclonal antibodies to treat infectious and immunomodulated diseases. Operating globally with research and development activities based in Australia and the United States, Immuron is headquartered in Carlton, Australia. The company is focused on utilizing its proprietary technologies to improve patient outcomes while strategically expanding its product pipeline, position...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Immuron Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMRN pay dividends?

Immuron Ltd ADR (IMRN) does not currently pay a regular dividend.

What is IMRN's market cap?

Immuron Ltd ADR (IMRN) has a market capitalization of $7.45M with a current stock price of $0.84.